跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX-Nitrofurantoin 50 mg capsule blister - TGA Drug Approval Details
Approvals
/
TGA
/
ARX-Nitrofurantoin 50 mg capsule blister
Approved
STANDARD
ARX-Nitrofurantoin 50 mg capsule blister
Luminarie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ee686fe9ea13e5f5
Company
Luminarie Pty Ltd
Type
Standard
Approval Details
Approval Id
ee686fe9ea13e5f5
Product Name
ARX-Nitrofurantoin 50 mg capsule blister
Artg Id
373271
Artg Name
ARX-Nitrofurantoin 50 mg capsule blister
Sponsor
Luminarie Pty Ltd
Company Detail Path
/organization/luminarie-pty-ltd
Artg Date
2022-01-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/971072dd1b7d91cace4590db95a733b9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1b55d2b9c2180cad580d7b59cdcfc3cf.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ee686fe9ea13e5f5
Type
Standard
Back to TGA Approvals